Evidence map›Paper›PMID 28645959›Full record

SynthesisBMJ open2017

Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

Maria Pufulete, Rachel C Brierley, Chiara Bucciarelli-Ducci, John P Greenwood, Stephen Dorman, Richard A Anderson, Jessica Harris, Elisa McAlindon, Chris A Rogers, Barnaby C Reeves

Open access · goldAbstract readSystematic ReviewConsensus Statement
In one paragraph

Synthesis in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Maria PufuleteClinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.ORCID 0000-0002-1775-1949
Rachel C BrierleyClinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.
Chiara Bucciarelli-DucciNIHR Bristol Cardiovascular Research Unit, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
John P GreenwoodMultidisciplinary Cardiovascular Research Centre and Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Stephen DormanNIHR Bristol Cardiovascular Research Unit, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Richard A AndersonDepartment of Cardiology, University Hospitals of Wales, Cardiff, UK.
Jessica HarrisClinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.
Elisa McAlindonDepartment of Cardiology, New Cross Hospital, Wolverhampton, UK.
Chris A RogersClinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.
Barnaby C ReevesClinical Trials and Evaluation Unit, University of Bristol, Bristol, UK.
University of Bristol · GBUniversity Hospitals Bristol NHS Foundation Trust · GBNew Cross Hospital · GBUniversity Hospital of Wales · GBUniversity of Leeds · GB

Funding

British Heart FoundationDepartment of Health 11/2003/58
6 · The paper itself

Abstract

objectiveTo define important changes in management arising from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway.

designFormal consensus study using literature review and cardiologist expert opinion to formulate consensus statements and setting up a consensus panel to review the statements (by completing a web-based survey, attending a face-to-face meeting to discuss survey results and modify the survey to reflect group discussion and completing the modified survey to determine which statements were in consensus).

participantsFormulation of consensus statements: four cardiologists (two CMR and two interventional) and six non-clinical researchers. Formal consensus: seven cardiologists (two CMR and three interventional, one echocardiography and one heart failure). Forty-nine additional cardiologists completed the modified survey.

resultsThirty-seven draft statements describing changes in management following CMR were generated; these were condensed into 12 statements and reviewed through the formal consensus process. Three of 12 statements were classified in consensus in the first survey; these related to the role of CMR in identifying the cause of out-of-hospital cardiac arrest, providing a definitive diagnosis in patients found to have unobstructed arteries on angiography and identifying patients with left ventricular thrombus. Two additional statements were in consensus in the modified survey, relating to the ability of CMR to identify patients who have a poor prognosis after PPCI and assess ischaemia and viability in patients with multivessel disease.

conclusionThere was consensus that CMR leads to clinically important changes in management in five subgroups of patients who activate the PPCI pathway.

Indexed as

Magnetic Resonance ImagingPercutaneous Coronary InterventionCardiologistsCost-Benefit AnalysisDisease ManagementHumansCardiovascular magnetic resonanceformal consensusprimary percutaneous coronary interventionsystematic review

Identifiers

PMID28645959
PMCPMC5541580
OpenAlexW2612348950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.